5,474
Views
11
CrossRef citations to date
0
Altmetric
Review Articles

Relevance of organ(s)-on-a-chip systems to the investigation of food-gut microbiota-host interactions

ORCID Icon & ORCID Icon
Pages 463-488 | Received 28 Mar 2021, Accepted 31 Aug 2021, Published online: 30 Sep 2021

References

  • Abadpour S, Aizenshtadt A, Olsen PA, Shoji K, Wilson SR, Krauss S, Scholz H. 2020. Pancreas-on-a-Chip Technology for Transplantation Applications. Curr Diab Rep. 820(12):72–72.
  • Albillos A, de Gottardi A, Rescigno M. 2020. The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol. 72(3):558–577.
  • Almeida AS, Tran TTT, Ghosh TS, Ribiere C, Foley C, Alves LA, et al. 2021. Fiber-associated Lachnospiraceae reduce colon tumorigenesis by modulation of the tumor-immune microenvironment. bioRxiv.
  • And HC, Hoover DG. 2003. Bacteriocins and their Food Applications. Compr Rev Food Sci Food Saf. 2(3):82–100.
  • Angeloni C, Businaro R, Vauzour D. 2020. The role of diet in preventing and reducing cognitive decline. Curr Opin Psychiatry. 33(4):432–438.
  • Annunziata G, Arnone A, Ciampaglia R, Tenore GC, Novellino E. 2020. Fermentation of foods and beverages as a tool for increasing availability of bioactive compounds. focus on short-chain fatty acids. foods. Basel Switz. 9(8):999.
  • Arneth BM. 2018. Gut-brain axis biochemical signalling from the gastrointestinal tract to the central nervous system: gut dysbiosis and altered brain function. Postgrad Med J. 94(1114):446–452.
  • Ashammakhi N, Nasiri R, Barros N. R d, Tebon P, Thakor J, Goudie M, Shamloo A, Martin MG, Khademhosseini A. 2020. Gut-on-a-chip: Current progress and future opportunities. Biomaterials. 255:120196.
  • Azzini E, Maiani G. 2015. Chapter 23 - mediterranean diet: antioxidant nutritional status. In: Preedy VR, Watson RR, editors. The mediterranean diet [Internet]. San Diego: Academic Press. p. 249–257. Available from: https://www.sciencedirect.com/science/article/pii/B9780124078499000233.
  • Bajaj JS, Hylemon PB, Ridlon JM, Heuman DM, Daita K, White MB, Monteith P, Noble NA, Sikaroodi M, Gillevet PM. 2012. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol. 303(6):G675–85.
  • Balaguer F, Enrique M, Llopis S, Barrena M, Navarro V, Álvarez B, Chenoll E, Ramón D, Tortajada M, Martorell P, et al. 2021. Lipoteichoic acid from Bifidobacterium animalis subsp. lactis BPL1: a novel postbiotic that reduces fat deposition via IGF-1 pathway. Microb Biotechnol. 1–12.
  • Barash NR, Maloney JG, Singer SM, Dawson SC. 2017. Giardia Alters Commensal Microbial Diversity throughout the Murine Gut. Appleton JA, editor. Infect Immun. 85(6):e00948–16.
  • Barbieri F, Montanari C, Gardini F, Tabanelli G. 2019. Biogenic Amine Production by Lactic Acid Bacteria: A Review. Foods Basel Switz. 8(1):17.
  • Bartfeld S. 2016. Modeling infectious diseases and host-microbe interactions in gastrointestinal organoids. Dev Biol. 420(2):262–270.
  • Bastiaanssen TFS, Cowan CSM, Claesson MJ, Dinan TG, Cryan JF. 2019. Making sense of … the microbiome in psychiatry. Int J Neuropsychopharmacol. 22(1):37–52.
  • Bauer S, Wennberg Huldt C, Kanebratt KP, Durieux I, Gunne D, Andersson S, Ewart L, Haynes WG, Maschmeyer I, Winter A, et al. 2017. Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model. Sci Rep. 7(1):14620.
  • Beaurivage C, Kanapeckaite A, Loomans C, Erdmann KS, Stallen J, Janssen RAJ. 2020. Development of a human primary gut-on-a-chip to model inflammatory processes. Sci Rep. 10(1):21475.
  • Beaurivage C, Naumovska E, Chang YX, Elstak ED, Nicolas A, Wouters H, et al. 2019. Development of a gut-on-a-chip model for high throughput disease modeling and drug discovery. Int J Mol Sci. 20(22):5661.
  • Bein A, Shin W, Jalili-Firoozinezhad S, Park MH, Sontheimer-Phelps A, Tovaglieri A, Chalkiadaki A, Kim HJ, Ingber DE. 2018. Microfluidic organ-on-a-chip models of human intestine. Cell Mol Gastroenterol Hepatol. 5(4):659–668.
  • Belkaid Y, Hand TW. 2014. Role of the microbiota in immunity and inflammation. Cell. 157(1):121–141.
  • Bell V, Ferrão J, Pimentel L, Pintado M, Fernandes T. 2018. One health, fermented foods, and gut microbiota. Foods Basel Switz. 7(12):195.
  • Beulens JWJ, Booth SL, van den Heuvel EGHM, Stoecklin E, Baka A, Vermeer C. 2013. The role of menaquinones (vitamin K2) in human health. Br J Nutr. 110(8):1357–1368.
  • Bricks T, Paullier P, Legendre A, Fleury M-J, Zeller P, Merlier F, Anton PM, Leclerc E. 2014. Development of a new microfluidic platform integrating co-cultures of intestinal and liver cell lines. Toxicol in Vitro. 28(5):885–895.
  • Broussard JL, Devkota S. 2016. The changing microbial landscape of Western society: diet, dwellings and discordance. Mol Metab. 5(9):737–742.
  • Bulutoglu B, Rey-Bedón C, Kang YB, Mert S, Yarmush ML, Usta OB. 2019. A microfluidic patterned model of non-alcoholic fatty liver disease: applications to disease progression and zonation. Lab Chip. 19(18):3022–3031.
  • Cabrera-Rubio R, Patterson AM, Cotter PD, Beraza N. 2019. Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice. Sci Rep. 9(1):12324.
  • Camarillo-Guerrero LF, Almeida A, Rangel-Pineros G, Finn RD, Lawley TD. 2021. Massive expansion of human gut bacteriophage diversity. Cell. 184(4):1098–1109.e9.
  • Castaner O, Goday A, Park Y-M, Lee S-H, Magkos F, Shiow S-ATE, Schröder H. 2018. The Gut Microbiome Profile in Obesity: A Systematic Review. Int J Endocrinol.2018:4095789–4095789.
  • Celebioglu HU. 2021. Effects of potential synbiotic interaction between Lactobacillus rhamnosus GG and salicylic acid on human colon and prostate cancer cells. Arch Microbiol. 203(3):1221–1229. Available from:.
  • Ceppa F, Mancini A, Tuohy K. 2019. Current evidence linking diet to gut microbiota and brain development and function. Int J Food Sci Nutr. 70(1):1–19.
  • Chen HJ, Miller P, Shuler ML. 2018. A pumpless body-on-a-chip model using a primary culture of human intestinal cells and a 3D culture of liver cells. Lab Chip. 18(14):2036–2046.
  • Chen M, Sun Q, Giovannucci E, Mozaffarian D, Manson JE, Willett WC, Hu FB. 2014. Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. BMC Med. 12(1):215–215.
  • Chi M, Yi B, Oh S, Park D-J, Sung JH, Park S. 2015. A microfluidic cell culture device (μFCCD) to culture epithelial cells with physiological and morphological properties that mimic those of the human intestine. Biomed Microdevices. 17(3):9966.
  • Cho H‐J, Kim H‐J, Lee KJu, Lasli S, Ung A, Hoffman T, Nasiri R, Bandaru P, Ahadian S, Dokmeci MR, et al. 2021. Liver-on-a-chip: bioengineered multicellular liver microtissues for modeling advanced hepatic fibrosis driven through non-alcoholic fatty liver disease (Small 14/2021). Small. 17(14):2170061.
  • Choe A, Ha SK, Choi I, Choi N, Sung JH. 2017. Microfluidic Gut-liver chip for reproducing the first pass metabolism. Biomed Microdev. 19(1):4.
  • Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC. 2019. The microbiome and irritable bowel syndrome - a review on the pathophysiology, current research and future therapy. Front Microbiol.10:1136–1136.
  • Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, Harris HMB, Coakley M, Lakshminarayanan B, O'Sullivan O, et al. 2012. Gut microbiota composition correlates with diet and health in the elderly. Nature. 488(7410):178–184.
  • Codoñer FM, Ramírez-Bosca A, Climent E, Carrión-Gutierrez M, Guerrero M, Pérez-Orquín JM, Horga de la Parte J, Genovés S, Ramón D, Navarro-López V, et al. 2018. Gut microbial composition in patients with psoriasis. Sci Rep. 8(1):3812.
  • Collado MC, Vinderola G, Salminen S. 2019. Postbiotics: facts and open questions. A position paper on the need for a consensus definition. Benef Microbes. 10(7):711–719.
  • Cotter PD, Hill C, Ross RP. 2005. Bacteriocins: developing innate immunity for food. Nat Rev Microbiol. (10):777–3:788.
  • Crespo-Piazuelo D, Migura-Garcia L, Estellé J, Criado-Mesas L, Revilla M, Castelló A, Muñoz M, García-Casco JM, Fernández AI, Ballester M, et al. 2019. Association between the pig genome and its gut microbiota composition. Sci Rep. 9(1):8791.
  • Cryan JF, O'Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, et al. 2019. The microbiota-gut-brain axis. Physiol Rev. 99(4):1877–2013.
  • Dahlberg T, Stangner T, Zhang H, Wiklund K, Lundberg P, Edman L, Andersson M. 2018. 3D printed water-soluble scaffolds for rapid production of PDMS micro-fluidic flow chambers. Sci Rep. 8(1):3372.
  • De Filippis F, Pasolli E, Ercolini D. 2020. The food-gut axis: lactic acid bacteria and their link to food, the gut microbiome and human health. FEMS Microbiol Rev. 44(4):454–489.
  • de Goffau MC, Lager S, Salter SJ, Wagner J, Kronbichler A, Charnock-Jones DS, Peacock SJ, Smith GCS, Parkhill J. 2018. Recognizing the reagent microbiome. Nat Microbiol. 3(8):851–853.
  • de Haan P, Ianovska MA, Mathwig K, van Lieshout GAA, Triantis V, Bouwmeester H, Verpoorte E. 2019. Digestion-on-a-chip: a continuous-flow modular microsystem recreating enzymatic digestion in the gastrointestinal tract. Lab Chip. 19(9):1599–1609.
  • de Haan P, Santbergen MJC, van der Zande M, Bouwmeester H, Nielen MWF, Verpoorte E. 2021. A versatile, compartmentalised gut-on-a-chip system for pharmacological and toxicological analyses. Sci Rep. 11(1):4920.
  • De Simone C. 2018. Letter: what gastroenterologists should know about VSL#3. Aliment Pharmacol Ther. 47(5):698–699.
  • Degen LP, Phillips SF. 1996. Variability of gastrointestinal transit in healthy women and men. Gut. 39(2):299–305.
  • Deng J, Wei W, Chen Z, Lin B, Zhao W, Luo Y. 2019. Engineered liver-on-a-chip platform to mimic liver functions and its biomedical applications: a review. Micromachines. 10(10):676.
  • Devkota S, Chang EB. 2015. Interactions between diet, bile acid metabolism, gut microbiota, and inflammatory bowel diseases. Dig Dis. 33(3):351–356.
  • Diaz M, Kellingray L, Akinyemi N, Adefiranye OO, Olaonipekun AB, Bayili GR, Ibezim J, Du Plessis AS, Houngbédji M, Kamya D, et al. Comparison of the microbial composition of African fermented foods using amplicon sequencing. Sci Rep. 2019. 9(1):13863.
  • Diaz M, Ladero V, Redruello B, Sanchez-Llana E, del Rio B, Fernandez M, Martin MC, Alvarez MA. 2016. A PCR-DGGE method for the identification of histamine-producing bacteria in cheese. Food Control. 63:216–223.
  • Distrutti E, Monaldi L, Ricci P, Fiorucci S. 2016. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol. 22(7):2219–2241.
  • Donaldson GP, Lee SM, Mazmanian SK. 2016. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol. 14(1):20–32.
  • Donia MS, Fischbach MA. 2015. Human Microbiota. Small molecules from the human microbiota. Science. 349(6246):1254766.
  • Donkers JM, Eslami Amirabadi H, van de Steeg E. 2021. Intestine-on-a-chip: next level in vitro research model of the human intestine. Curr Opin Toxicol.25:6–14.
  • Eain MMG, Baginska J, Greenhalgh K, Fritz JV, Zenhausern F, Wilmes P. 2017. Engineering solutions for representative models of the gastrointestinal human-microbe interface. Engineering. 3(1):60–65.
  • Esch EW, Bahinski A, Huh D. 2015. Organs-on-chips at the frontiers of drug discovery. Nat Rev Drug Discov. 14(4):248–260.
  • Filosa S, Di Meo F, Crispi S. 2018. Polyphenols-gut microbiota interplay and brain neuromodulation. Neural Regen Res. 13(12):2055–2059.
  • Firth J, Gangwisch JE, Borisini A, Wootton RE, Mayer EA. 2020. Food and mood: how do diet and nutrition affect mental wellbeing? BMJ.369:m2382.
  • Freag MS, Namgung B, Reyna Fernandez ME, Gherardi E, Sengupta S, Jang HL. 2021. Human nonalcoholic steatohepatitis on a chip. Hepatol Commun. 5(2):217–233.
  • Fritz JV, Desai MS, Shah P, Schneider JG, Wilmes P. 2013. From meta-omics to causality: experimental models for human microbiome research. Microbiome. 1(1):14.
  • Garcia-Gutierrez E, Mayer MJ, Cotter PD, Narbad A. 2019. Gut microbiota as a source of novel antimicrobials. Gut Microbes. 10(1):1–21.
  • Garcia-Gutierrez E, Narbad A, Rodríguez JM. 2020. Autism spectrum disorder associated with gut microbiota at immune, metabolomic, and neuroactive level. Front Neurosci.14:578666.
  • Garcia-Gutierrez E. 2019. New antimicrobials to target gut and food pathogens. [Thesis]. University of East Anglia
  • Ghosh TS, Rampelli S, Jeffery IB, Santoro A, Neto M, Capri M, Giampieri E, Jennings A, Candela M, Turroni S, et al. 2020. Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries. Gut. 69(7):1218–1228.
  • Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, et al. 2017. Expert consensus document: the international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 14(8):491–502.
  • Gibson PR, Halmos EP, Muir JG. 2020. Review article: FODMAPS, prebiotics and gut health-the FODMAP hypothesis revisited. Aliment Pharmacol Ther. 52(2):233–246.
  • Gokaltun A, Yarmush ML, Asatekin A, Usta OB. 2017. Recent advances in nonbiofouling PDMS surface modification strategies applicable to microfluidic technology. Technology. 5(1):1–12.
  • Gori M, Simonelli MC, Giannitelli SM, Businaro L, Trombetta M, Rainer A. 2016. Investigating nonalcoholic fatty liver disease in a liver-on-a-chip microfluidic device. PLOS One. 11(7):e0159729.
  • Grangette C, Nutten S, Palumbo E, Morath S, Hermann C, Dewulf J, Pot B, Hartung T, Hols P, Mercenier A, et al. 2005. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A. 102(29):10321–10326.
  • Grassart A, Malardé V, Gobaa S, Sartori-Rupp A, Kerns J, Karalis K, Marteyn B, Sansonetti P, Sauvonnet N. 2019. Bioengineered human organ-on-chip reveals intestinal microenvironment and mechanical forces impacting shigella infection. Cell Host Microbe. 26(3):435–444.e4.
  • Guenat OT, Berthiaume F. 2018. Incorporating mechanical strain in organs-on-a-chip: lung and skin. Biomicrofluidics. 12(4):042207–042207.
  • Guinane CM, Cotter PD. 2013. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol. 6(4):295–308.
  • Hassan S, Sebastian S, Maharjan S, Lesha A, Carpenter A-M, Liu X, Xie X, Livermore C, Zhang YS, Zarrinpar A, et al. 2020. Liver-on-a-chip models of fatty liver disease. Hepatology. 71(2):733–740.
  • Hermann E, Foligne B. 2017. Healthy gut microbiota can resolve undernutrition. Hepatobiliary Surg Nutr. 6(2):141–143.
  • Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al. 2014. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 11(8):506–514.
  • Hills RD, Jr, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. 2019. Gut microbiome: profound implications for diet and disease. Nutrients. 11(7):1613.
  • Holscher HD. 2017. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 8(2):172–184.
  • Huh D, Hamilton GA, Ingber DE. 2011. From 3D cell culture to organs-on-chips. Trends Cell Biol. 21(12):745–754.
  • Ingber DE. 2018. Developmentally inspired human ‘organs on chips. Dev Camb Engl. 145(16):dev156125.
  • Isaacs-Ten A, Echeandia M, Moreno-Gonzalez M, Brion A, Goldson A, Philo M, et al. 2020. Intestinal microbiome-macrophage crosstalk contributes to cholestatic liver disease by promoting intestinal permeability. Hepatology. 72:2090–2108. Available from:.
  • Jalili-Firoozinezhad S, Gazzaniga FS, Calamari EL, Camacho DM, Fadel CW, Bein A, Swenor B, Nestor B, Cronce MJ, Tovaglieri A, et al. 2019. A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip. Nat Biomed Eng. 3(7):520–531.
  • Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. 2015. Role of the normal gut microbiota. World J Gastroenterol. 21(29):8787–8803.
  • Jang K-J, Otieno MA, Ronxhi J, Lim H-K, Ewart L, Kodella KR, Petropolis DB, Kulkarni G, Rubins JE, Conegliano D, et al. 2019. Reproducing human and cross-species drug toxicities using a Liver-Chip. Sci Transl Med. 11(517):eaax5516.
  • Johnson KVA. 2020. Gut microbiome composition and diversity are related to human personality traits. Hum Microb J. 15. DOI:https://doi.org/10.1016/j.humic.2019.100069
  • Junaid A, Mashaghi A, Hankemeier T, Vulto P. 2017. An end-user perspective on Organ-on-a-Chip: assays and usability aspects. Curr Opin Biomed Eng. 1:15–22.
  • Kaarj K, Yoon J-Y. 2019. Methods of delivering mechanical stimuli to organ-on-a-chip. Micromachines. 10(10):700.
  • Kasendra M, Luc R, Yin J, Manatakis DV, Kulkarni G, Lucchesi C, et al. 2020. Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model. eLife.9:e50135.
  • Kilic T, Navaee F, Stradolini F, Renaud P, Carrara S. 2018. Organs-on-chip monitoring: sensors and other strategies. Microphysiol Syst. 1:1–1. [cited 2018 Jan 1]; Available from: http://mps.amegroups.com/article/view/4689.
  • Kim HJ, Huh D, Hamilton G, Ingber DE. 2012. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip. 12(12):2165–2174.
  • Kim HJ, Ingber DE. 2013. Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation. Integr Biol. 5(9):1130–1140.
  • Kim HJ, Li H, Collins JJ, Ingber DE. 2016. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc Natl Acad Sci USA. 113(1):E7–15.
  • Kim J, Koo B-K, Knoblich JA. 2020. Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol. 21(10):571–584.
  • Konstantinov SR, Smidt H, de Vos WM, Bruijns SCM, Singh SK, Valence F, et al. 2008. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci. 105(49):19474.
  • Kostic AD, Howitt MR, Garrett WS. 2013. Exploring host-microbiota interactions in animal models and humans. Genes Dev. 27(7):701–718.
  • Koudoufio M, Desjardins Y, Feldman F, Spahis S, Delvin E, Levy E. 2020. Insight into polyphenol and gut microbiota crosstalk: are their metabolites the key to understand protective effects against metabolic disorders? Antioxid Basel Switz. 9(10):982.
  • Kowalski K, Mulak A. 2019. Brain-gut-microbiota axis in alzheimer's disease. J Neurogastroenterol Motil. 25(1):48–60.
  • Kulthong K, Duivenvoorde L, Mizera BZ, Rijkers D, Dam G. Oegema G, Puzyn T, Bouwmeester H, van der Zande M. 2018.Implementation of a dynamic intestinal gut-on-a-chip barrier model for transport studies of lipophilic dioxin congeners. RSC Adv. 8(57):32440–32453.
  • Kulthong K, Duivenvoorde L, Sun H, Confederat S, Wu J, Spenkelink B, de Haan L, Marin V, van der Zande M, Bouwmeester H, et al. 2020. Microfluidic chip for culturing intestinal epithelial cell layers: Characterization and comparison of drug transport between dynamic and static models. Toxicol in Vitro. 65:104815.
  • Laforest-Lapointe I, Arrieta M-C. 2018. Microbial eukaryotes: a missing link in gut microbiome studies. mSystems. 3(2):e00201–17.
  • Lawrence GW, Begley M, Cotter PD, Guinane CM. 2020. The more we learn, the less we know: deciphering the link between human gut fusobacteria and colorectal cancer. Dig Med Res. 3:21–21. [Internet].[cited 2020 Jan 1].
  • Lea T. 2015. Caco-2 cell line. In: Verhoeckx K, Cotter P, López-Expósito I, Kleiveland C, Lea T, Mackie A, et al. editors. The impact of food bioactives on health: in vitro and ex vivo models [Internet]. Cham: Springer International Publishing. p. 103–111. Available from:.
  • Lebeer S, Claes I, Tytgat HLP, Verhoeven TLA, Marien E, von Ossowski I, Reunanen J, Palva A, Vos W. M d, Keersmaecker SCJD, et al. 2012. Functional analysis of lactobacillus rhamnosus gg pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl Environ Microbiol. 78(1):185–193.
  • Lee B, Moon KM, Kim CY. 2018. Tight junction in the intestinal epithelium: its association with diseases and regulation by phytochemicals. J Immunol Res.2018:2645465–2645465.
  • Leng B, Sørensen MB, Kot W, Thymann T, Krych L, Nielsen DS. 2019. Severe gut microbiota dysbiosis caused by malnourishment can be partly restored during 3 weeks of refeeding with fortified corn-soy-blend in a piglet model of childhood malnutrition. BMC Microbiol. 19(1):277.
  • Li C, Kwok L-Y, Mi Z, Bala J, Xue J, Yang J, Ma Y, Zhang H, ChenY 2017Characterization of the angiotensin-converting enzyme inhibitory activity of fermented milks produced with Lactobacillus casei. J Dairy Sci. . 100(12):9495–9507.
  • Li X, Tian T. 2018. Recent advances in an organ-on-a-chip: biomarker analysis and applications. Anal Methods. 10(26):3122–3130.
  • Lin A, Sved Skottvoll F, Rayner S, Pedersen-Bjergaard S, Sullivan G, Krauss S, Ray Wilson S, Harrison S. 2020. 3D cell culture models and organ-on-a-chip: Meet separation science and mass spectrometry. Electrophoresis.41(1-2):56–64.
  • Linares DM, Gómez C, Renes E, Fresno JM, Tornadijo ME, Ross RP, Stanton C. 2017. Lactic acid bacteria and bifidobacteria with potential to design natural biofunctional health-promoting dairy foods. Front Microbiol. 8:846–846.
  • Linares DM, O'Callaghan TF, O'Connor PM, Ross RP, Stanton C. 2016. Streptococcus thermophilus APC151 Strain Is Suitable for the Manufacture of Naturally GABA-Enriched Bioactive Yogurt. Front Microbiol.7:1876–1876.
  • Liwinski T, Zenouzi R, John C, Ehlken H, Rühlemann MC, Bang C, Groth S, Lieb W, Kantowski M, Andersen N, et al. 2020. Alterations of the bile microbiome in primary sclerosing cholangitis. Gut. 69(4):665–672.
  • Low LA, Mummery C, Berridge BR, Austin CP, Tagle DA. 2021. Organs-on-chips: into the next decade. Nat Rev Drug Discov. 20(5):345–361.
  • Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. 2012. Diversity, stability and resilience of the human gut microbiota. Nature. 489(7415):220–230.
  • Lynch KE, Parke EC, O’Malley MA. 2019. How causal are microbiomes? A comparison with the Helicobacter pylori explanation of ulcers. Biol Philos. 34(6):62.
  • Ma C, Peng Y, Li H, Chen W. 2021. Organ-on-a-chip: a new paradigm for drug development. Trends Pharmacol Sci. 42(2):119–133.
  • Ma L, Kim J, Hatzenpichler R, Karymov MA, Hubert N, Hanan IM, Chang EB, Ismagilov RF. 2014. Gene-targeted microfluidic cultivation validated by isolation of a gut bacterium listed in Human Microbiome Project's Most Wanted taxa. Proc Natl Acad Sci USA. 111(27):9768–9773.
  • Mackie A, Mulet-Cabero A-I, Torcello-Gómez A. 2020. Simulating human digestion: developing our knowledge to create healthier and more sustainable foods. Food Funct. 11:9397–9431. DOI:https://doi.org/10.1039/D0FO01981J
  • Macori G, Cotter PD. 2018. Novel insights into the microbiology of fermented dairy foods. Curr Opin Biotechnol.49:172–178.
  • Maeda Y, Takeda K. 2017. Role of gut microbiota in rheumatoid arthritis. J Clin Med. 6(6):60.
  • Mah J-H, Park YK, Jin YH, Lee J-H, Hwang H-J. 2019. Bacterial production and control of biogenic amines in Asian fermented soybean foods. Foods Basel Switz. 8(2):85.
  • Makki K, Deehan EC, Walter J, Bäckhed F. 2018. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 23(6):705–715.
  • Marco ML, Heeney D, Binda S, Cifelli CJ, Cotter PD, Foligné B, Gänzle M, Kort R, Pasin G, Pihlanto A, et al. 2017. Health benefits of fermented foods: microbiota and beyond. Curr Opin Biotechnol.44:94–102.
  • Marco ML, Sanders ME, Gänzle M, Arrieta MC, Cotter PD, De Vuyst L, Hill C, Holzapfel W, Lebeer S, Merenstein D, et al. 2021.The international scientific association for probiotics and prebiotics (isapp) consensus statement on fermented foods. Nat Rev Gastroenterol Hepatol. 18(3):196–208. Available from:.
  • Maschmeyer I, Lorenz AK, Schimek K, Hasenberg T, Ramme AP, Hübner J, Lindner M, Drewell C, Bauer S, Thomas A, et al. 2015. A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. Lab Chip. 15(12):2688–2699.
  • Mata A, Fleischman AJ, Roy S. 2005. Characterization of Polydimethylsiloxane (PDMS) Properties for Biomedical Micro/Nanosystems. Biomed Microdevices. 7(4):281–293.
  • Maurer M, Gresnigt MS, Last A, Wollny T, Berlinghof F, Pospich R, Cseresnyes Z, Medyukhina A, Graf K, Gröger M, et al. 2019. A three-dimensional immunocompetent intestine-on-chip model as in vitro platform for functional and microbial interaction studies. Biomaterials.220:119396.
  • McDonald JC, Whitesides GM. 2002. Poly(dimethylsiloxane) as a material for fabricating microfluidic devices. Acc Chem Res. 35(7):491–499.
  • McGrane MM, Essery E, Obbagy J, Lyon J, Macneil P, Spahn J, Van Horn L. 2011. Dairy consumption, blood pressure, and risk of hypertension: an evidence-based review of recent literature. Curr Cardiovasc Risk Rep. 5(4):287–298.
  • Merra G, Noce A, Marrone G, Cintoni M, Tarsitano MG, Capacci A, et al. 2021. Influence of mediterranean diet on human gut microbiota. Nutrients. 13(1):7.
  • Meslier V, Laiola M, Roager HM, De Filippis F, Roume H, Quinquis B, Giacco R, Mennella I, Ferracane R, Pons N, et al. 2020. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake. Gut. 69(7):1258–1268.
  • Mikkonen R, Puistola P, Jönkkäri I, Mäntysalo M. 2020. Inkjet printable polydimethylsiloxane for all-inkjet-printed multilayered soft electrical applications. ACS Appl Mater Interfaces. 12(10):11990–11997.
  • Milani C, Duranti S, Bottacini F, Casey E, Turroni F, Mahony J, et al. 2017. The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiol Mol Biol Rev. 81(4):e00036–e00017.
  • Million M, Angelakis E, Maraninchi M, Henry M, Giorgi R, Valero R, Vialettes B, Raoult D. 2013. Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli. Int J Obes. 37(11):1460–1466.
  • Miraglia F, Colla E. 2019. Microbiome, parkinson’s disease and molecular mimicry. Cells. 8(3):222.
  • Molinero N, Ruiz L, Milani C, Gutiérrez-Díaz I, Sánchez B, Mangifesta M, Segura J, Cambero I, Campelo AB, García-Bernardo CM, et al. 2019. The human gallbladder microbiome is related to the physiological state and the biliary metabolic profile. Microbiome. 7(1):100.
  • Molinero N, Ruiz L, Sánchez B, Margolles A, Delgado S. 2019. Intestinal bacteria interplay with bile and cholesterol metabolism: implications on host physiology. Front Physiol.10:185–185.
  • Moreno-Gonzalez M, Beraza N. 2021. The role of the microbiome in liver cancer. Cancers. 13(10). DOI:https://doi.org/10.3390/cancers13102330
  • Morton JT, Aksenov AA, Nothias LF, Foulds JR, Quinn RA, Badri MH, Swenson TL, Van Goethem MW, Northen TR, Vazquez-Baeza Y, et al. 2019. Learning representations of microbe-metabolite interactions. Nat Methods. 16(12):1306–1314.
  • Mousa WK, Athar B, Merwin NJ, Magarvey NA. 2017. Antibiotics and specialized metabolites from the human microbiota. Nat Prod Rep. 34(11):1302–1331.
  • Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. 2011. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 364(25):2392–2404.
  • Myhrstad MCW, Tunsjø H, Charnock C, Telle-Hansen VH. 2020. Dietary Fiber, gut microbiota, and metabolic regulation-current status in human randomized trials. Nutrients. 12(3):859.
  • Nampoothiri KM, Beena DJ, Vasanthakumari DS, Ismail B. 2017. Chapter 3 - Health Benefits of Exopolysaccharides in Fermented Foods. In: Frias J, Martinez-Villaluenga C, Peñas E, editors. Fermented Foods in Health and Disease Prevention [Internet]. Boston: Academic Press; p. 49–62. Available from: http://www.sciencedirect.com/science/article/pii/B9780128023099000030.
  • Nash AK, Auchtung TA, Wong MC, Smith DP, Gesell JR, Ross MC, Stewart CJ, Metcalf GA, Muzny DM, Gibbs RA, et al. 2017. The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome. 5(1):153.
  • Nawroth JC, Petropolis DB, Manatakis DV, Maulana TI, Burchett G, Schlünder K, et al. 2020. Modeling alcoholic liver disease in a human Liver-Chip. bioRxiv.
  • Nguyen TLA, Vieira-Silva S, Liston A, Raes J. 2015. How informative is the mouse for human gut microbiota research? Dis Model Mech. 8(1):1–16.
  • Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. 2018. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 11(1):1–10.
  • Nkamga VD, Henrissat B, Drancourt M. 2017. Archaea: essential inhabitants of the human digestive microbiota. Hum Microbiome J.3:1–8.
  • Nogacka AM, Ruas-Madiedo P, Gómez E, Solís G, Fernández N, Suárez M, Suárez A, Salazar N, de Los Reyes-Gavilán CG, Gueimonde M, et al. 2018. Real-time monitoring of HT29 epithelial cells as an in vitro model for assessing functional differences among intestinal microbiotas from different human population groups. J Microbiol Methods.152:210–216.
  • Nogacka AM. 2020. Modelos de interacción microbiota-hospedador en el entorno intestinal y su aplicación en el desarrollo de productos probióticos y prebióticos [Tesis Doctoral]. Oviedo: Universidad de Oviedo.
  • Novak R, Didier M, Calamari E, Ng CF, Choe Y, Clauson SL, et al. 2018. Scalable fabrication of stretchable, dual channel, microfluidic organ chips. J Vis Exp JoVE.140:58151.
  • Nueno-Palop C, Narbad A. 2011. Probiotic assessment of Enterococcus faecalis CP58 isolated from human gut. Int J Food Microbiol. 145(2-3):390–394.
  • Ochs CJ, Kasuya J, Pavesi A, Kamm RD. 2014. Oxygen levels in thermoplastic microfluidic devices during cell culture. Lab Chip. 14(3):459–462.
  • Odijk M, van der Meer AD, Levner D, Kim HJ, van der Helm MW, Segerink LI, Frimat J-P, Hamilton GA, Ingber DE, van den Berg A, et al. 2015. Measuring direct current trans-epithelial electrical resistance in organ-on-a-chip microsystems. Lab Chip. 15(3):745–752.
  • O'Donnell MM, Rea MC, Shanahan F, Ross RP. 2018. The use of a mini-bioreactor fermentation system as a reproducible, high-throughput ex vivo batch model of the distal colon. Front Microbiol.9:1844.
  • Oedit A, Vulto P, Ramautar R, Lindenburg PW, Hankemeier T. 2015. Lab-on-a-Chip hyphenation with mass spectrometry: strategies for bioanalytical applications. Curr Opin Biotechnol.31:79–85.
  • Onyszkiewicz M, Gawrys-Kopczynska M, Konopelski P, Aleksandrowicz M, Sawicka A, Koźniewska E, Samborowska E, Ufnal M. 2019. Butyric acid, a gut bacteria metabolite, lowers arterial blood pressure via colon-vagus nerve signaling and GPR41/43 receptors. Pflugers Arch.471(11-12):1441–1453.
  • Parian AM, Mullin GE, Langhorst J, Brown AC. 2018. Chapter 50 - inflammatory bowel disease. In: Rakel D, editor. Integrative medicine 4th ed. [Internet]. Philadelphia (PA): Elsevier; p. 501–516.e8. Available from: https://www.sciencedirect.com/science/article/pii/B9780323358682000505.
  • Pasolli E, De Filippis F, Mauriello IE, Cumbo F, Walsh AM, Leech J, Cotter PD, Segata N, Ercolini D. 2020. Large-scale genome-wide analysis links lactic acid bacteria from food with the gut microbiome. Nat Commun. 11(1):2610.
  • Pasolli E, Schiffer L, Manghi P, Renson A, Obenchain V, Truong DT, Beghini F, Malik F, Ramos M, Dowd JB, et al. 2017. Accessible, curated metagenomic data through Experiment Hub. Nat Methods. 14(11):1023–1024.
  • Patil Y, Gooneratne R, Ju X-H. 2020. Interactions between host and gut microbiota in domestic pigs: a review. Gut Microbes. 11(3):310–334.
  • Pessione E, Cirrincione S. 2016. Bioactive molecules released in food by lactic acid bacteria: encrypted peptides and biogenic amines. Front Microbiol.7:876.
  • Pontifex MG, Malik MMAH, Connell E, Müller M, Vauzour D. 2021. Citrus polyphenols in brain health and disease: current perspectives. Front Neurosci.15:115.
  • Ramadan Q, Jafarpoorchekab H, Huang C, Silacci P, Carrara S, Koklü G, Ghaye J, Ramsden J, Ruffert C, Vergeres G, et al. 2013. NutriChip: nutrition analysis meets microfluidics. Lab Chip. 13(2):196–203.
  • Redfern WS, Bialecki R, Ewart L, Hammond TG, Kinter L, Lindgren S, Pollard CE, Rolf M, Valentin J-P. 2010. Impact and prevalence of safety pharmacology-related toxicities throughout the pharmaceutical life cycle. Seventh Annu Focus Issue Methods Saf Pharmacol Part II. 62(2):e29.
  • Reid G, Younes JA, Van der Mei HC, Gloor GB, Knight R, Busscher HJ. 2011. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol. 9(1):27–38.
  • Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, et al. 2019. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell. 178(4):795–806.e12.
  • Rodríguez JM, Murphy K, Stanton C, Ross RP, Kober OI, Juge N, Avershina E, Rudi K, Narbad A, Jenmalm MC, et al. 2015. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Health Dis. 26:26050–26050.
  • Rogal J, Zbinden A, Schenke-Layland K, Loskill P. 2019. Stem-cell based organ-on-a-chip models for diabetes research. Adv Drug Deliv Rev.140:101–128.
  • Ronaldson-Bouchard K, Vunjak-Novakovic G. 2018. Organs-on-a-chip: a fast track for engineered human tissues in drug development. Cell Stem Cell. 22(3):310–324.
  • Rowan S, Jiang S, Korem T, Szymanski J, Chang M-L, Szelog J, Cassalman C, Dasuri K, McGuire C, Nagai R, et al. 2017. Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration. Proc Natl Acad Sci USA. 114(22):E4472–E4481.
  • Salazar N, Valdés-Varela L, González S, Gueimonde M, de Los Reyes-Gavilán CG. 2017. Nutrition and the gut microbiome in the elderly. Gut Microbes. 8(2):82–97.
  • Sambuy Y, De Angelis I, Ranaldi G, Scarino M, Stammati A, Zucco F. 2005. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol. 21(1):1–26.
  • Sangwan V, Tomar SK, Ali B, Singh RRB, Singh AK. 2015. Production of β-galactosidase from streptococcus thermophilus for galactooligosaccharides synthesis. J Food Sci Technol. 52(7):4206–4215.
  • Şanlier N, Gökcen BB, Sezgin AC. 2019. Health benefits of fermented foods. Crit Rev Food Sci Nutr. 59(3):506–527.
  • Saqib S, Akram A, Halim SA, Tassaduq R. 2017. Sources of β-galactosidase and its applications in food industry. 3 Biotech. 7(1):79–79.
  • Saubade F, Hemery YM, Guyot J-P, Humblot C. 2017. Lactic acid fermentation as a tool for increasing the folate content of foods. Crit Rev Food Sci Nutr. 257(18):3894–3910.
  • Sender R, Fuchs S, Milo R. 2016. Are we really vastly outnumbered? revisiting the ratio of bacterial to host cells in humans. Cell. 164(3):337–340.
  • Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, et al. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA. 110(9):3507–3512.
  • Shah P, Fritz JV, Glaab E, Desai MS, Greenhalgh K, Frachet A, Niegowska M, Estes M, Jäger C, Seguin-Devaux C, et al. 2016. A microfluidics-based in vitro model of the gastrointestinal human-microbe interface. Nat Commun. 7(1):11535.
  • Shakerian M, Razavi SH, Ziai SA, Khodaiyan F, Yarmand MS, Moayedi A. 2015. Proteolytic and ACE-inhibitory activities of probiotic yogurt containing non-viable bacteria as affected by different levels of fat, inulin and starter culture. J Food Sci Technol. 52(4):2428–2433.
  • Shanahan F, Ghosh TS, O'Toole PW. 2021. The Healthy microbiome-what is the definition of a healthy gut microbiome?. Gastroenterology. 160(2):483–494.
  • Sharma N, Angural S, Rana M, Puri N, Kondepudi KK, Gupta N. 2020. Phytase producing lactic acid bacteria: Cell factories for enhancing micronutrient bioavailability of phytate rich foods. Trends Food Sci Technol. 96:1–12.
  • Shi Z. 2019. Gut microbiota: an important link between Western Diet and chronic diseases. Nutrients. 11(10):2287.
  • Shik Mun K, Arora K, Huang Y, Yang F, Yarlagadda S, Ramananda Y, Abu-El-Haija M, Palermo JJ, Appakalai BN, Nathan JD, et al. 2019. Patient-derived pancreas-on-a-chip to model cystic fibrosis-related disorders. Nat Commun. 10(1):3124.
  • Shimizu H, Masujima Y, Ushiroda C, Mizushima R, Taira S, Ohue-Kitano R, Kimura I. 2019. Dietary short-chain fatty acid intake improves the hepatic metabolic condition via FFAR3. Sci Rep. 9(1):16574.
  • Shin W, Kim HJ. 2018. Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip. Proc Natl Acad Sci USA. 115(45):E10539–E10547.
  • Shkoporov AN, Clooney AG, Sutton TDS, Ryan FJ, Daly KM, Nolan JA, McDonnell SA, Khokhlova EV, Draper LA, Forde A, et al. 2019. The human gut virome is highly diverse, stable, and individual specific. Cell Host Microbe. 26(4):527–541.e5.
  • Silva CCG, Silva SPM, Ribeiro SC. 2018. Application of Bacteriocins and Protective Cultures in Dairy Food Preservation. Front Microbiol. 9:594–594.
  • Simon Sarkadi L. 2017. Chapter 27 - Biogenic Amines in Fermented Foods and Health Implications. In: Frias J, Martinez-Villaluenga C, Peñas E, editors. Fermented foods in health and disease prevention. Boston: Academic Press. p. 625–651. Available from: https://www.sciencedirect.com/science/article/pii/B9780128023099000273.
  • So D, Whelan K, Rossi M, Morrison M, Holtmann G, Kelly JT, Shanahan ER, Staudacher HM, Campbell KL. 2018. Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. Am J Clin Nutr. 107(6):965–983.
  • Sokolowska P, Janikiewicz J, Jastrzebska E, Brzozka Z, Dobrzyn A. 2020. Combinations of regenerative medicine and Lab-on-a-chip systems: New hope to restoring the proper function of pancreatic islets in diabetes. Biosens Bioelectron.167:112451.
  • Sokovic Bajic S, Djokic J, Dinic M, Veljovic K, Golic N, Mihajlovic S, Tolinacki M. 2019. GABA-producing natural dairy isolate from artisanal zlatar cheese attenuates gut inflammation and strengthens gut epithelial barrier in vitro. Front Microbiol.10:527.
  • Spano G, Russo P, Lonvaud-Funel A, Lucas P, Alexandre H, Grandvalet C, Coton E, Coton M, Barnavon L, Bach B, et al. 2010. Biogenic amines in fermented foods. Eur J Clin Nutr.64(Suppl 3):S95–S100.
  • Spence JR, Mayhew CN, Rankin SA, Kuhar MF, Vallance JE, Tolle K, Hoskins EE, Kalinichenko VV, Wells SI, Zorn AM, et al. 2011. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature. 470(7332):105–109.
  • Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ. 2015. TEER measurement techniques for in vitro barrier model systems. J Lab Autom. 20(2):107–126.
  • Sriram G, Alberti M, Dancik Y, Wu B, Wu R, Feng Z, Ramasamy S, Bigliardi PL, Bigliardi-Qi M, Wang Z, et al. 2018. Full-thickness human skin-on-chip with enhanced epidermal morphogenesis and barrier function. Mater Today. 21(4):326–340.
  • Steinway SN, Saleh J, Koo B-K, Delacour D, Kim D-H. 2020. Human microphysiological models of intestinal tissue and gut microbiome. Front Bioeng Biotechnol. 8:725–725.
  • Storck LJ, Imoberdorf R, Ballmer PE. 2019. Nutrition in gastrointestinal disease: liver, pancreatic, and inflammatory bowel disease. J Clin Med. 8(8):1098.
  • Strati F, Cavalieri D, Albanese D, De Felice C, Donati C, Hayek J, Jousson O, Leoncini S, Renzi D, Calabrò A, et al. 2017. New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome. 5(1):24–24.
  • Sun J, Furio L, Mecheri R, van der Does AM, Lundeberg E, Saveanu L, Chen Y, van Endert P, Agerberth B, Diana J, et al. 2015. Pancreatic β-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity. 43(2):304–317.
  • Sutton TDS, Hill C. 2019. Gut bacteriophage: current understanding and challenges. Front Endocrinol.10:784.
  • Swanson KS, Gibson GR, Hutkins R, Reimer RA, Reid G, Verbeke K, Scott KP, Holscher HD, Azad MB, Delzenne NM, et al. 2020. The international scientific association for probiotics and prebiotics (isapp) consensus statement on the definition and scope of synbiotics. Nat Rev Gastroenterol Hepatol. 17(11):687–701.
  • Takahashi T. 2011. Flow Behavior of Digesta and the Absorption of Nutrients in the Gastrointestine. J Nutr Sci Vitaminol. 57(4):265–273.
  • Thomas RM, Jobin C. 2020. Microbiota in pancreatic health and disease: the next frontier in microbiome research. Nat Rev Gastroenterol Hepatol. 17(1):53–64.
  • Tiew PY, Mac Aogain M, Ali NABM, Thng KX, Goh K, Lau KJX, Chotirmall SH. 2020. The mycobiome in health and disease: emerging concepts, methodologies and challenges. Mycopathologia. 185(2):207–231.
  • Tilg H, Moschen AR. 2014. Microbiota and diabetes: an evolving relationship. Gut. 63(9):1513–1521.
  • Trietsch SJ, Naumovska E, Kurek D, Setyawati MC, Vormann MK, Wilschut KJ, Lanz HL, Nicolas A, Ng CP, Joore J, et al. 2017. Membrane-free culture and real-time barrier integrity assessment of perfused intestinal epithelium tubes. Nat Commun. 8(1):262.
  • Tsamandouras N, Chen WLK, Edington CD, Stokes CL, Griffith LG, Cirit M. 2017. Integrated gut and liver microphysiological systems for quantitative in vitro pharmacokinetic studies . 9(5):1499–1512.
  • van den Berg A, Mummery CL, Passier R, van der Meer AD. 2019. Personalised organs-on-chips: functional testing for precision medicine. Lab Chip. 19(2):198–205.
  • van der Helm MW, van der Meer AD, Eijkel JCT, van den Berg A, Segerink LI. 2016. Microfluidic organ-on-chip technology for blood-brain barrier research. Tissue Barriers. 4(1):e1142493.
  • van Poll ML, Zhou F, Ramstedt M, Hu L, Huck WTS. A self-assembly approach to chemical micropatterning of Poly(dimethylsiloxane). Angew Chem Int Ed Engl. 2007. 46(35):6634–6637.
  • Vergères G, Bogicevic B, Buri C, Carrara S, Chollet M, Corbino-Giunta L, Egger L, Gille D, Kopf-Bolanz K, Laederach K, et al. 2012. The NutriChip project-translating technology into nutritional knowledge. Br J Nutr. 108(5):762–768.
  • Vernetti L, Gough A, Baetz N, Blutt S, Broughman JR, Brown JA, Foulke-Abel J, Hasan N, In J, Kelly E, et al. 2017. Corrigendum: functional coupling of human microphysiology systems: intestine, liver, kidney proximal tubule, blood-brain barrier and skeletal Muscle. Sci Rep. 7(1):44517.
  • Villarreal-Soto SA, Bouajila J, Pace M, Leech J, Cotter PD, Souchard J-P, Taillandier P, Beaufort S. 2020. Metabolome-microbiome signatures in the fermented beverage, Kombucha. Int J Food Microbiol. 333:108778.
  • Villenave R, Wales SQ, Hamkins-Indik T, Papafragkou E, Weaver JC, Ferrante TC, Bahinski A, Elkins CA, Kulka M, Ingber DE, et al. 2017. Human gut-on-a-chip supports polarized infection of coxsackie B1 virus in vitro. PLoS One.12(2):e0169412.
  • Vinderola G, Reinheimer J, Salminen S. 2019. The enumeration of probiotic issues: from unavailable standardised culture media to a recommended procedure? Int Dairy J.96:58–65.
  • Virumbrales-Muñoz M, Ayuso JM, Gong MM, Humayun M, Livingston MK, Lugo-Cintrón KM, McMinn P, Álvarez-García YR, Beebe DJ. 2020. Microfluidic lumen-based systems for advancing tubular organ modeling. Chem Soc Rev. 49(17):6402–6442.
  • Walter J, Armet AM, Finlay BB, Shanahan F. 2020. Establishing or exaggerating causality for the gut microbiome: lessons from human microbiota-associated rodents. Cell. 180(2):221–232.
  • Walther B, Karl JP, Booth SL, Boyaval P. 2013. Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements. Adv Nutr. 4(4):463–473.
  • Wang H, Yan Y, Yi X, Duan Y, Wang J, Li S, Luo L, Huang T, Inglis B, Li X, et al. 2019. Histopathological features and composition of gut microbiota in rhesus monkey of alcoholic liver disease. Front Microbiol.10:165.
  • Wang YI, Carmona C, Hickman JJ, Shuler ML. 2018. Multiorgan microphysiological systems for drug development: strategies, advances, and challenges. Adv Healthc Mater. 7(2):10.
  • Warburton R. 2017. A microbiological assessment of the human biliary tract in health and disease. [Thesis]. University of East Anglia.
  • Wekerle H, Hohlfeld R. 2016. Chapter 9 - gut microbiota in multiple sclerosis: a bioreactor driving brain autoimmunity. In: Arnon R, Miller A, editors. Translational neuroimmunology in multiple sclerosis. San Diego: Academic Press; p. 113–125. Available from: http://www.sciencedirect.com/science/article/pii/B978012801914600009X.
  • Wilkinson M. 2019. The potential of organ on chip technology for replacing animal testing. Leiden: Brill. p. 639–653. Available from: https://brill.com/view/book/edcoll/9789004391192/BP000033.xml.
  • Williams CF, Walton GE, Jiang L, Plummer S, Garaiova I, Gibson GR. 2015. Comparative analysis of intestinal tract models. Annu Rev Food Sci Technol. 6(1):329–350.
  • Wolf MP, Salieb-Beugelaar GB, Hunziker P. 2018. PDMS with designer functionalities—Properties, modifications strategies, and applications. Prog Polym Sci.83:97–134.
  • Wu J, He Z, Chen Q, Lin J-M. 2016. Biochemical analysis on microfluidic chips. TrAC Trends Anal Chem. 80:213–231.
  • Xiang Y, Wen H, Yu Y, Li M, Fu X, Huang S. 2020. Gut-on-chip: recreating human intestine in vitro. J Tissue Eng. 11:2041731420965318.
  • Xu C, Zhu H, Qiu P. 2019. Aging progression of human gut microbiota. BMC Microbiol. 19(1):236.
  • Yeste J, Illa X, Alvarez M, Villa R. 2018. Engineering and monitoring cellular barrier models. J Biol Eng.12:18–18.
  • Zhang B, Korolj A, Lai BFL, Radisic M. 2018. Advances in organ-on-a-chip engineering. Nat Rev Mater. 3(8):257–278.
  • Zhang K, Dai H, Liang W, Zhang L, Deng Z. 2019. Fermented dairy foods intake and risk of cancer. Int J Cancer. 144(9):2099–2108.
  • Zhang YS, Aleman J, Shin SR, Kilic T, Kim D, Mousavi Shaegh SA, Massa S, Riahi R, Chae S, Hu N, et al. 2017. Multisensor-integrated organs-on-chips platform for automated and continual in situ monitoring of organoid behaviors. Proc Natl Acad Sci USA. 114(12):E2293–E2302.
  • Zinöcker MK, Lindseth IA. 2018. The Western Diet–microbiome-host interaction and its role in metabolic disease. Nutrients. 10(3):365.
  • Zmora N, Zilberman-Schapira G, Suez J, Mor U, Dori-Bachash M, Bashiardes S, Kotler E, Zur M, Regev-Lehavi D, Brik RB-Z, et al. 2018. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell. 174(6):1388–1405.e21.